Please login to the form below

Not currently logged in
Email:
Password:

Novasep names Michel Spagnol CEO

Joins contract manufacturing firm from Shasun

Novasep Michel Spagnol Novasep has appointed Michel Spagnol as its new president and CEO, succeeding Patrick Glaser who returns to the US.

Spagnol joins French contract manufacturing firm Novasep from Shasun, where he was president and chief technology officer.

Prior to Shasun, Spagnol spent his career at Rhodia in Lyon, France and New Jersey, US, where he progressed first in technical R&D leadership roles and subsequently transitioned to business development as sales and marketing vice president of Rhodia Pharma Solutions.  

He joins Novasep as the company looks to expand through investments in its manufacturing capabilities in both France and China.

“His track record in delivering customer driven solutions, his international and scientific background coupled with his extensive management experience, longstanding knowledge and relationships in the pharmaceutical industry will be strong assets for the company,” said Roger-Marc Nicoud, founder and non-executive chairman of the board of Novasep.

9th July 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Ask the writers: Transitioning from academia to medical writing
Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset
By James Aird...
Guide
How to embrace behavioural science principles in healthcare MR...